Interní Med. 2007; 9(7): 345-348

Screening for Diabetic Retinopathy

MUDr. Natália Beszédešová
Klinika nemocí očních a optometrie, LF MU FN u sv. Anny, Brno

Diabetic retinopathy (DR) is the leading cause of blindness among working – age people in developed countries. The complex treatment strategies are 90 % effective in preventing the ocurrence of vision loss. These strategies include management of patient’s systemic disorder, active screening for DR and specialized ophthalmic treatment. Reference to a timely and regular eye examination of the diabetic patient is an essential requirement for the effective screening for DR allowing an early detection and treatment of DR. The diabetologists, internists and general practitioners play an important role in the screening programme as they refer the patients to eye examination and provide good control of diabetes and systemic risk factors resulting in reducing onset and progression of DR. The purpose of this article is to emphasize the importance of early detection and managing of DR in order to prevent, retard or reverse vision loss.

Keywords: diabetic retinopathy, screening for diabetic retinopathy, vision loss

Published: December 18, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Beszédešová N. Screening for Diabetic Retinopathy. Interní Med. 2007;9(7):345-348.
Download citation

References

  1. Aiello LP et al. Systemic considerations in the management of diabetic retinopathy. Am J Ophthalmol. 2001; 132: 760-776. Go to original source... Go to PubMed...
  2. American Academy of Ophthalmology Retina Panel. Diabetic Retinopathy Preffered Practise Patterns. 2003, www.aao.org.
  3. Coyne KS et al. The impact of diabetic retinopathy: perspectives from patient focus groups. Family Practice 2004; 21: 447-453. Go to original source... Go to PubMed...
  4. Dadiková B. Péče o nemocné s cukrovkou v České republice v letech 2000 - 2004. Praha 2. 6. 2005, www.uzis.cz.
  5. Friedecký B. Laboratorní diagnostika a sledování stavu diabetu mellitu. 1. 9. 2005, www.diab.cz.
  6. Hawthorne CL et al. The cost of blindness. An analysis of the costs of visual impairment and blindness in the United Kingdom issued by the guide dogs for the blind association, ESL July 2003, www.healthyeyes.org.uk.
  7. Hollay E et al. Diabetes mellitus a hypertenze. Interní Med. 2006; 5: 219-222.
  8. International diabetes federation' s world diabetes day 2002 focuses on eye complications. Brussels, November 14, 2002, www.idf.org.
  9. Kalvodová B. Diabetická retinopatie - komentář. Medicína po promoci 2004; 5: 31-34.
  10. Kalvodová B. Screening diabetické retinopatie. In: Rozsíval P et al. Trendy soudobé oftalmologie, svazek 3. Praha: Galén 2006, 246 s.
  11. Kolář P. Epidemiologie diabetické retinopatie, 21-22. In: Sborník abstrakt Diabetes mellitus - oční komplikace, VI. minisympozium, Olomouc 2005, 59 s.
  12. Loyková V. Léčba diabetu 2. typu. 12-13. In: Sborník abstrakt Diabetes mellitus - oční komplikace, VI. minisympozium, Olomouc 2005, 59 s.
  13. O'Shea JG, Harvey RB. Current perspectives of diabetic retinopathy. http://medweb.bham.ac.uk.
  14. Sosna T, Bouček P, Fišer I. Diabetická retinopatie. Praha: Jiří Cendelín 2001, 255 s.
  15. Standardy péče o diabetes mellitus 2. typu. 13. 12. 2005, www.diab.cz.
  16. Standardy pro diagnostiku a léčbu diabetické retinopatie a jejích komplikací. Doporučení ČDS a České vitreoretinální spoločnosti. 2004, www.diab.cz.
  17. The FIELD study investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005; 366 (9500): 1849-61. Go to original source... Go to PubMed...
  18. Wilkinson ChP et al. Classification od diabetic retinopathy: A proposed international clinical disease severity grading scale for diabetic retinopathy and diabetic macular edema. 2002, www.medscape.com.
  19. World Health Organization. Facts related to chronic diseases: Fact Sheet - Diabetes. 2006, www.who.int.
  20. www.visionfordiabetes.com.
  21. Žáčková V. Péče o diabetika v ambulantní praxi. Med Pro Praxi. 2006; 2: 70-75.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.